NO992603L - Kreatinpyruvater og fremgangsmÕte for fremstilling av disse - Google Patents

Kreatinpyruvater og fremgangsmÕte for fremstilling av disse

Info

Publication number: NO992603L
Authority: NO; Norway
Prior art keywords: creatine; pyruvates; processes; preparation; field
Prior art date: 1996-12-20

Application number

NO992603A

Other languages

English (en)

Other versions

NO311354B1 (no

NO992603D0 (no

Inventor

Ivo Pischel

Stefan Weiss

Original Assignee

Sueddeutsche Kalkstickstoff

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-12-20

Filing date

1999-05-31

Publication date

1999-05-31

1996-12-20 Priority claimed from DE19653225A external-priority patent/DE19653225A1/de

1999-05-31 Application filed by Sueddeutsche Kalkstickstoff filed Critical Sueddeutsche Kalkstickstoff

1999-05-31 Publication of NO992603D0 publication Critical patent/NO992603D0/no

1999-05-31 Publication of NO992603L publication Critical patent/NO992603L/no

2001-11-19 Publication of NO311354B1 publication Critical patent/NO311354B1/no

Links

CVSVTCORWBXHQV-UHFFFAOYSA-N anhydrous creatine Natural products NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 title abstract 5
229960003624 creatine Drugs 0.000 title abstract 4
239000006046 creatine Substances 0.000 title abstract 4
-1 Creatine pyruvates Chemical class 0.000 title abstract 3
LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 abstract 2
208000008589 Obesity Diseases 0.000 abstract 1
206010033307 Overweight Diseases 0.000 abstract 1
210000000577 adipose tissue Anatomy 0.000 abstract 1
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
230000006735 deficit Effects 0.000 abstract 1
235000015872 dietary supplement Nutrition 0.000 abstract 1
208000028867 ischemia Diseases 0.000 abstract 1
230000007774 longterm Effects 0.000 abstract 1
235000020824 obesity Nutrition 0.000 abstract 1
229910052760 oxygen Inorganic materials 0.000 abstract 1
239000001301 oxygen Substances 0.000 abstract 1
229940107700 pyruvic acid Drugs 0.000 abstract 1
239000002516 radical scavenger Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
- C07C279/14—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/185—Saturated compounds having only one carboxyl group and containing keto groups
- C07C59/19—Pyruvic acid

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Hematology (AREA)
Obesity (AREA)
Diabetes (AREA)
Epidemiology (AREA)
Child & Adolescent Psychology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Extrusion Moulding Of Plastics Or The Like (AREA)
Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)

NO19992603A 1996-12-20 1999-05-31 Kreatinpyruvater og fremgangsmåte for fremstilling av disse NO311354B1 (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DE19653225A DE19653225A1 (de)	1996-12-20	1996-12-20	Kreatin-pyruvate und Verfahren zu deren Herstellung
US08/893,423 US6166249A (en)	1996-12-20	1997-07-11	Creatine pyruvates
PCT/EP1997/007121 WO1998028263A1 (de)	1996-12-20	1997-12-18	Kreatin-pyruvate und verfahren zu deren herstellung

Publications (3)

Publication Number	Publication Date
NO992603D0 NO992603D0 (no)	1999-05-31
NO992603L true NO992603L (no)	1999-05-31
NO311354B1 NO311354B1 (no)	2001-11-19

Family

ID=26032506

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO19992603A NO311354B1 (no)	1996-12-20	1999-05-31	Kreatinpyruvater og fremgangsmåte for fremstilling av disse

Country Status (22)

Country	Link
US (1)	US6172111B1 (no)
EP (1)	EP0894083B1 (no)
JP (1)	JP3090960B2 (no)
CN (1)	CN1076343C (no)
AT (1)	ATE186295T1 (no)
AU (1)	AU727524B2 (no)
BG (1)	BG63537B1 (no)
BR (1)	BR9711954A (no)
CA (1)	CA2255665C (no)
CZ (1)	CZ293282B6 (no)
DE (1)	DE59700666D1 (no)
DK (1)	DK0894083T3 (no)
ES (1)	ES2139465T3 (no)
GR (1)	GR3031754T3 (no)
IL (1)	IL127148A (no)
NO (1)	NO311354B1 (no)
NZ (1)	NZ332830A (no)
PL (1)	PL330279A1 (no)
RU (1)	RU2179970C2 (no)
SK (1)	SK283195B6 (no)
TR (1)	TR199900470T2 (no)
WO (1)	WO1998028263A1 (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1051914A1 (de) *	1999-05-08	2000-11-15	DSM Fine Chemicals Austria GmbH	Verwendung von Kreatin als Futterzusatz
US6242491B1 (en) *	1999-06-25	2001-06-05	Rima Kaddurah-Daouk	Use of creatine or creatine compounds for skin preservation
DE19929995B4 (de)	1999-06-30	2004-06-03	Skw Trostberg Ag	Verwendung von Kreatin und/oder Kreatin-Derivaten zur Behandlung von Befindlichkeitsstörungen bei Frauen
AU6153200A (en) *	1999-06-30	2001-01-22	Skw Trostberg Aktiengesellschaft	Use of creatine and/or creatine derivatives for treating feelings of ill-health in women
DE10003835A1 (de) *	2000-01-28	2001-08-16	Sueddeutsche Kalkstickstoff	Formulierungen bei Dehydratationszuständen
US20030212136A1 (en)	2001-09-14	2003-11-13	Vennerstrom Jonathan L.	Creatine ester pronutrient compounds and formulations
EP1688139A1 (en) *	2000-09-14	2006-08-09	Board of Regents of the University of Nebraska	Creatine ester pronutrient compounds and formulations
DE10064312C2 (de) *	2000-12-22	2003-05-22	Degussa	Cholinpyruvat-Hydrat, Verfahren zu dessen Herstellung, Cholinpyruvat-Hydrat enthaltende Formulierung sowie deren Verwendung
US6838562B2 (en) *	2003-04-01	2005-01-04	Sal Abraham	Process for preparing a creatine heterocyclic acid salt and method of use
DE10355716A1 (de) *	2003-11-26	2005-06-23	Beiersdorf Ag	Kosmetische Zubereitungen mit einem Gehalt Kreatin und/oder Kreatinderivaten und/oder Kreatinin und/oderKreatininderivaten und organischen Verdickern
RS50556B (sr)	2004-06-09	2010-05-07	Alzchem Trostberg Gmbh.	Guanidino sirćetna kiselina kao dodatak hrani za životinje
DE102006031441B4 (de) *	2006-07-05	2011-12-29	Hans Matt	Orales Creatin-Supplement, sowie Verfahren zur Herstellung desselben
DE102007004781A1 (de)	2007-01-31	2008-08-07	Alzchem Trostberg Gmbh	Verwendung von Guanidinoessigsäure(-Salzen) zur Herstellung eines gesundheitsfördernden Mittels
DE102007030495A1 (de)	2007-06-30	2009-01-15	Alzchem Trostberg Gmbh	Verwendung einer eine Kreatin-Komponente enthaltende Zusammensetzung zur Verbesserung der Gedächtnisleistung, der Merkfähigkeit, des Langzeitgedächtnisses und zur Vorbeugung geistiger Ermüdungszustände
DE102007053369A1 (de)	2007-11-09	2009-07-02	Alzchem Trostberg Gmbh	Verwendung einer eine Kreatin-Komponente enthaltende Zusammensetzung zur Verbesserung der männlichen Fruchtbarkeit
DE102007062288A1 (de)	2007-12-21	2009-06-25	Alzchem Trostberg Gmbh	Kreatin-Zubereitung und Verfahren zu deren Herstellung
EP2303040A1 (en) *	2008-06-06	2011-04-06	PhytoLab GmbH & Co. KG	Synergistic enhancement of cellular ergogenic nutrient uptake, like creatine or carnitine, with tarragon
US8466198B2 (en) *	2008-09-02	2013-06-18	Bruce Kneller	Compositions comprising creatine salts and methods of use thereof
US8999375B2 (en) *	2009-12-29	2015-04-07	Hill's Pet Nutrition, Inc.	Compositions including pyruvate for companion animals and methods of use thereof
WO2014198787A1 (en)	2013-06-12	2014-12-18	Anabio Technologies Limited	A process for producing microcapsules comprising an active component encapsulated, protected and stabilised within a protein shell
EP3772985A1 (en)	2018-03-27	2021-02-17	Evonik Operations GmbH	Use of guanidinoacetic acid and/or creatine in aquaculture

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US1967400A (en) *	1930-03-27	1934-07-24	Schering Kahlbaum Ag	Production of guanidino fatty acids
FR4508M (no) *	1965-05-06	1966-10-17
US4548937A (en) *	1981-04-01	1985-10-22	Montefiore Hospital	Method for preventing body fat deposition in mammals
DE3273611D1 (en) *	1982-11-10	1986-11-13	Laevosan Gmbh & Co Kg	Infusion solutions for heart therapy
US5091171B2 (en) *	1986-12-23	1997-07-15	Tristrata Inc	Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use
GB9215746D0 (en) *	1992-07-24	1992-09-09	Hultman Eric	A method of increasing creatine supply depot
FR2698628B1 (fr) *	1992-12-02	1995-02-17	Fournier Ind & Sante	Analogues de 15-déoxyspergualine, leur procédé de préparation et leur utilisation en thérapeutique.
JP3213666B2 (ja) *	1994-02-28	2001-10-02	治彦末岡	クレアチン飲料の製造方法
US5627172A (en) *	1994-03-04	1997-05-06	Natural Supplement Association, Incorporated	Method for reduction of serum blood lipids or lipoprotein fraction
US5536751A (en) *	1994-05-09	1996-07-16	The United States Of America As Represented By The Secretary Of The Army	Pharmaceutical alpha-keto carboxylic acid compositions method of making and use thereof
IT1271687B (it) *	1994-08-04	1997-06-04	Flamma Spa	Sali organici idrosolubili della creatina
US5886040A (en) *	1997-06-17	1999-03-23	Amt Labs, Inc.	Creatine pyruvate salt with enhanced palatability

1997
- 1997-12-18 CN CN97195889A patent/CN1076343C/zh not_active Expired - Fee Related
- 1997-12-18 ES ES97954423T patent/ES2139465T3/es not_active Expired - Lifetime
- 1997-12-18 JP JP10528354A patent/JP3090960B2/ja not_active Expired - Lifetime
- 1997-12-18 BR BR9711954A patent/BR9711954A/pt not_active IP Right Cessation
- 1997-12-18 CZ CZ19983626A patent/CZ293282B6/cs not_active IP Right Cessation
- 1997-12-18 IL IL12714897A patent/IL127148A/en not_active IP Right Cessation
- 1997-12-18 AT AT97954423T patent/ATE186295T1/de not_active IP Right Cessation
- 1997-12-18 EP EP97954423A patent/EP0894083B1/de not_active Expired - Lifetime
- 1997-12-18 NZ NZ332830A patent/NZ332830A/xx unknown
- 1997-12-18 SK SK1556-98A patent/SK283195B6/sk unknown
- 1997-12-18 TR TR1999/00470T patent/TR199900470T2/xx unknown
- 1997-12-18 AU AU58576/98A patent/AU727524B2/en not_active Ceased
- 1997-12-18 WO PCT/EP1997/007121 patent/WO1998028263A1/de not_active Ceased
- 1997-12-18 DK DK97954423T patent/DK0894083T3/da active
- 1997-12-18 PL PL97330279A patent/PL330279A1/xx unknown
- 1997-12-18 DE DE59700666T patent/DE59700666D1/de not_active Expired - Fee Related
- 1997-12-18 RU RU98122207/04A patent/RU2179970C2/ru not_active IP Right Cessation
- 1997-12-18 CA CA002255665A patent/CA2255665C/en not_active Expired - Fee Related
1998
- 1998-11-18 BG BG102932A patent/BG63537B1/bg unknown
1999
- 1999-05-12 US US09/310,323 patent/US6172111B1/en not_active Expired - Fee Related
- 1999-05-31 NO NO19992603A patent/NO311354B1/no not_active IP Right Cessation
- 1999-11-04 GR GR990402819T patent/GR3031754T3/el unknown

Also Published As

Publication number	Publication date
EP0894083B1 (de)	1999-11-03
PL330279A1 (en)	1999-05-10
NO311354B1 (no)	2001-11-19
HK1020718A1 (en)	2000-05-19
US6172111B1 (en)	2001-01-09
JP3090960B2 (ja)	2000-09-25
SK155698A3 (en)	1999-05-07
CZ362698A3 (cs)	1999-03-17
NO992603D0 (no)	1999-05-31
CZ293282B6 (cs)	2004-03-17
ES2139465T3 (es)	2000-02-01
SK283195B6 (sk)	2003-03-04
BG102932A (en)	1999-09-30
ATE186295T1 (de)	1999-11-15
NZ332830A (en)	2000-04-28
CA2255665A1 (en)	1998-07-02
TR199900470T2 (xx)	1999-06-21
WO1998028263A1 (de)	1998-07-02
DK0894083T3 (da)	2000-04-03
AU727524B2 (en)	2000-12-14
BG63537B1 (bg)	2002-04-30
JPH11509560A (ja)	1999-08-24
GR3031754T3 (en)	2000-02-29
CA2255665C (en)	2002-05-14
IL127148A0 (en)	1999-09-22
CN1224416A (zh)	1999-07-28
EP0894083A1 (de)	1999-02-03
AU5857698A (en)	1998-07-17
DE59700666D1 (de)	1999-12-09
BR9711954A (pt)	1999-08-24
CN1076343C (zh)	2001-12-19
IL127148A (en)	2002-11-10
RU2179970C2 (ru)	2002-02-27

Legal Events

Date	Code	Title	Description
2002-08-05	MM1K	Lapsed by not paying the annual fees	Free format text: LAPSED IN JUNE 2002

Publication	Publication Date	Title
NO992603D0 (no)	1999-05-31	Kreatinpyruvater og fremgangsmÕte for fremstilling av disse
Higuchi et al.	1985	Superoxide dismutase and catalase in skeletal muscle: adaptive response to exercise
Walters	1980	The exposure of humans to nitrite
Almeida et al.	2002	The use of the oxidative stress responses as biomarkers in Nile tilapia (Oreochromis niloticus) exposed to in vivo cadmium contamination
Swendseid et al.	1963	Ratios of essential-to-nonessential amino acids in plasma from rats fed different kinds and amounts of proteins and amino acids
TR199900450A2 (en)	1999-10-21	�ikolata par�ac�klar�
RU98122207A (ru)	2000-09-27	Пируваты креатина и способ их получения
Itoh et al.	1973	Comparative effects of casein and amino acid mixture simulating casein on growth and food intake in rats
Byington et al.	1972	Effect of different levels and proportions of methionine, cystine, choline, and inorganic sulfur on growth and body composition of young rats
ATE70699T1 (de)	1992-01-15	Futtermittelzusatz zur verbesserung des wachstums bei landwirtschaftlichen nutztieren.
de Romaña et al.	1981	Fasting and postprandial plasma free amino acids of infants and children consuming exclusively potato protein
Milinković-Tur et al.	2009	Age-related antioxidant enzyme activities and lipid peroxidation in heart muscles of broiler chickens fed with supplementary organic selenium
Petrulea et al.	2009	THYROID HORMONES IN EXCESS INDUCE OXIDATIVE STRESS IN RATS.
Wu et al.	2019	Effect of astaxanthin supplementation on antioxidant capacity, blood lactate and blood uric acid metabolism in human recovery stage after exercise
Hänninen et al.	1998	Oxidative metabolism in skeletal muscle
SHIMENO et al.	1993	Inclusion of oligosaccharide in soybean meal diet for fingerling yellowtail
Marin et al.	2012	Peloidotherapy in osteoarthritis-modulation of oxidative stress
Turkki et al.	1983	Riboflavin status of rats fed two levels of protein during energy deprivation and subsequent repletion
Goerner et al.	1932	The Metabolism of Sulphydril Compounds in Tumor Tissue
Yadav et al.	2016	EFFECT OF ZINC AND SELENIUM SUPPLIMENTATION ON BLOOD BIOCHEMICAL PROFILE IN PURE BRED BARBARI GOAT.
Smalley	1986	NITROGEN AND METHIONINE NUTRITURE OF THE WEANLING KITTEN (REQUIREMENT, PLASMA AMINO ACIDS, D-METHIONINE, TRANSAMINASE)
Cardoso	1991	The nitrate content of drinking water in Portugal
Böhles	1984	Response to Drs. Paul and Adibi's Letter
Park et al.	1973	Nutrition value of chlorella (I)
Schwarz	1983	INTERACTIONS OF BRANCHED-CHAIN AMINO ACIDS IN THE IN VITRO MUSCLE.